CVE-2026-56693NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the create_agent delivery-action handler that performs privileged central-database writes without host-side authorization check…
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the create_agent delivery-action handler that performs privileged central-database writes without host-side authorization checks. Confined agent containers can invoke create_agent to create arbitrary agent groups, container configurations, and destinations, escalating beyond their intended confinement boundary.
- CVSS
- 5.5 MEDIUM (v3.1, NVD)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N
- Weakness (CWE)
- CWE-602
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Sep 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/nanocoai/nanoclaw/commit/ac37ecbfd6b9d14fdfa1598a6412a8ffdbeaef45
- https://github.com/nanocoai/nanoclaw/pull/2720
- https://www.vulncheck.com/advisories/nanoclaw-privilege-escalation-via-unauthorized-create-agent-system-action
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.